Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Brain and Central Nervous System Tumors: early-phase trial registry
1 of 55 indexed Brain and Central Nervous System Tumors trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #254 of 28,707 conditions by registered trial count.
55 US clinical trials · 1 currently recruiting · #254 of 28,707 conditions by registered trial count
Brain and Central Nervous System Tumors: 55 US clinical trials tracked, 1 recruiting.
Brain and Central Nervous System Tumors is the subject of 55 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 40 in Phase 1-2 (earlier-stage). The most active sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, running 6 of these trials.
Enrollment posture brief
Registry condition brain-and-central-nervous-system-tumors
OPEN 1 | RECR 2% | LATE 7 | EARLY 40 | RANK #254 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Coronary Disease (3% recruiting · 36 trials)
Brain and Central Nervous System Tumors lists 1 open slots (2% of 55 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Brain and Central Nervous System Tumors on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Brain and Central Nervous System Tumors is recruiting below its size-band peers.
1 of 55 indexed trials (1.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Brain and Central Nervous System Tumors trials is spread across many organizations.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins accounts for 6 of 55 trials (10.9%). 24 distinct sponsors appear on at least one study for this condition label.
-
Most Brain and Central Nervous System Tumors trials plan to enrol fewer than 100 people.
Median target enrolment is 53 among the 46 trials that report a genuine target (sentinel values excluded). 33 of those (71.7%) plan for fewer than 100 participants.
-
Brain and Central Nervous System Tumors research is mostly interventional.
49 interventional and 6 observational studies make up this index (89.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
55 total, page 2 of 2
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Duke University
NCT00005951
EMD 121974 in Treating Patients With Progressive or Recurrent Glioma
New Approaches to Brain Tumor Therapy Consortium
NCT00006093
Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain
National Cancer Institute (NCI)
NCT00032097
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT00004041
Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
Dartmouth-Hitchcock Medical Center
NCT00005813
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 25 |
| Phase 2 | 15 |
| Phase 3 | 7 |
Top Sponsors
Named interventions
Most-linked intervention names on Brain and Central Nervous System Tumors records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Brain and Central Nervous System Tumors trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Brain and Central Nervous System Tumors page
55 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Brain and Central Nervous System Tumors trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins sponsors the most Brain and Central Nervous System Tumors trials on record, review their full trial history before evaluating a specific study. See Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Brain and Central Nervous System Tumors condition card totals 55 registered trials; most-linked intervention radiation therapy; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.